Recently, Chinese nucleic acid testing companies have been controversial and accused of making huge profits during the COVID-19 pandemic. Among them, a company called Nucleus Gene has aroused widespread public doubts.
ByteDance's healthcare business is stepping into an accelerated period of resource integration, and a huge healthcare ecosystem is slowly forming.
Yuyue Medical, a Chinese medical device manufacturer, announced on September 19 that internet giant Tencent plans to invest 291 million yuan ($41.5 million) in its subsidiary, Xunjie Medical.
China's National Medical Products Administration granted approval on August 31 to Tencent Healthcare (Shenzhen) Co., Ltd. for the registration of its innovative medical device.
Regarding recent reports, Chinese medical treatment crowdfunding platform Waterdrop responded that the so-called intermediaries were operated by some malicious third-party commercial organizations.
According to a document disclosed by the Hong Kong Stock Exchange (HKEx) on August 17, Dingdang Health, a digital medical services provider, has passed its listing hearing. Its sponsors are CICC and CMB International.
A pair of ByteDance subsidiaries have reportedly achieved a 100% shareholding ratio in Amcare, a high-end Chinese women's and children's hospital, as part of a move to explore the offline medical services sector.